These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4329372)

  • 1. Significance of splanchnic proteases in the production of a toxic factor in hemorrhagic shock.
    Glenn TM; Lefer AM
    Circ Res; 1971 Oct; 29(4):338-49. PubMed ID: 4329372
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of the pancreas in the pathogenesis of circulatory shock.
    Lefer AM; Glenn TM
    Adv Exp Med Biol; 1971 Oct; 23(0):311-35. PubMed ID: 5006110
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanisms of production of circulatory shock factors in isolated perfused pancreas.
    Ferguson WW; Glenn TM; Lefer AM
    Am J Physiol; 1972 Feb; 222(2):450-7. PubMed ID: 5058387
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of a myocardial depressant factor in the pathogenesis of circulatory shock.
    Lefer AM
    Fed Proc; 1970; 29(6):1836-47. PubMed ID: 5482718
    [No Abstract]   [Full Text] [Related]  

  • 5. Inadequacy of steroids in the treatment of severe hemorrhagic shock.
    Raflo GT; Jones RC; Wangensteen SL
    Am J Surg; 1975 Sep; 130(3):321-7. PubMed ID: 1166920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic hydrolases and the formation of a myocardial depressant factor in shock.
    Lefer AM; Barenholz Y
    Am J Physiol; 1972 Nov; 223(5):1103-9. PubMed ID: 4540125
    [No Abstract]   [Full Text] [Related]  

  • 7. Protective effect of pancreatic duct ligation in splanchnic ischemia shock.
    Glenn TM; Herlihy BL; Ferguson WW; Lefer AM
    Am J Physiol; 1972 May; 222(5):1278-84. PubMed ID: 5022386
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanism of the protective effects of prostaglandins E1 and F2 alpha in canine endotoxin shock.
    Raflo GT; Wangensteen SL; Glenn TM; Lefer AM
    Eur J Pharmacol; 1973 Oct; 24(1):86-95. PubMed ID: 4585594
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of lysosomes in the pathogenesis of splanchnic ischemia shock in cats.
    Glenn TM; Lefer AM
    Circ Res; 1970 Nov; 27(5):783-97. PubMed ID: 5486246
    [No Abstract]   [Full Text] [Related]  

  • 10. [Catabolic mucopolysaccharide protein metabolism in human organs].
    Platt D; Stein U
    Z Klin Chem Klin Biochem; 1969 Jul; 7(4):374-8. PubMed ID: 4243110
    [No Abstract]   [Full Text] [Related]  

  • 11. PLASMA CATHEPSIN-LIKE ACID PROTEINASE ACTIVITY DURING HEMORRHAGIC SHOCK.
    REICH T; DIEROLF BM; REYNOLDS BM
    J Surg Res; 1965 Mar; 5():116-9. PubMed ID: 14273766
    [No Abstract]   [Full Text] [Related]  

  • 12. Distribution and particle properties of the vacuolar apparatus of cardiac muscle tissue. I. Biochemical characterization of cardiac muscle lysosomes and the isolation and characterization of acid, neutral and alkaline proteases.
    Smith AL; Bird JW
    J Mol Cell Cardiol; 1975 Jan; 7(1):39-61. PubMed ID: 235655
    [No Abstract]   [Full Text] [Related]  

  • 13. Proteases and antiproteases in experimental low-flow states.
    Massion WH; Peschl L; Blümel G
    Adv Exp Med Biol; 1971 Oct; 23(0):381-92. PubMed ID: 5317478
    [No Abstract]   [Full Text] [Related]  

  • 14. Mammalian alpha-acetylglucosaminidase. Enzymic properties, tissue distribution, and intracellular localization.
    Weissmann B; Rowin G; Marshall J; Friederici D
    Biochemistry; 1967 Jan; 6(1):207-14. PubMed ID: 4291567
    [No Abstract]   [Full Text] [Related]  

  • 15. Production of a myocardial depressant factor in cardiogenic shock.
    Glenn TM; Lefer AM; Martin JB; Lovett WL; Morris JN; Wangensteen SL
    Am Heart J; 1971 Jul; 82(1):78-85. PubMed ID: 5581723
    [No Abstract]   [Full Text] [Related]  

  • 16. Protective action of methylprednisolone on the myocardium during experimental myocardial ischemia in the cat.
    Spath JA; Lane DL; Lefer AM
    Circ Res; 1974 Jul; 35(1):44-51. PubMed ID: 4841252
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of lysosomal disruption in the development of refractory shock.
    Bell ML; Herman AH; Egdahl RH; Smith EE; Rutenburg AM
    Surg Forum; 1970; 21():10-2. PubMed ID: 5514904
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of lysosomal instability in the development of refractory shock.
    Bell ML; Herman AH; Smith EE; Egdahl RH; Rutenburg AM
    Surgery; 1971 Sep; 70(3):341-7. PubMed ID: 5568517
    [No Abstract]   [Full Text] [Related]  

  • 19. Presence of a myocardial depressant factor in patients in circulatory shock.
    Lovett WL; Wangensteen SL; Glenn TM; Lefer AM
    Surgery; 1971 Aug; 70(2):223-31. PubMed ID: 5560183
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanism of the lack of a beneficial response to inotropic drugs in hemorrhagic shock.
    Lefer AM; Glenn TM; Lopez-Rasi AM; Kiechel SF; Ferguson WW; Wangensteen SL
    Clin Pharmacol Ther; 1971; 12(3):506-16. PubMed ID: 5567802
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.